- NEWS
- Update 15 August 2019
Treatment for extreme drug-resistant tuberculosis wins US government approval
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-019-02464-0
Updates & Corrections
-
Update 15 August 2019: This story has been updated with comment from Mel Spigelman, president of the TB Alliance, and Sharonann Lynch, TB policy advisor for Médecins Sans Frontières (also known as Doctors Without Borders).
References
Shah, N.S. et al. N. Engl. J. Med. 376, 243-253 (2017).